Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Premium quality, fair pricing
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Peptide therapy at Dr
Injections are quick, usually taking only a few minutes, with minimal discomfort
However, certain factors may influence whether or not you need a prescription to obtain B12 shots
US$ 26.82
US$ 27.63
US$ 25.06
US$ 21.49
